Dock protein family in brain development and neurological disease

Communicative and Integrative Biology

Volumn 6, Issue 6, 2013, Pages

  Shi, Lei ^a,b  

^a JINAN UNIVERSITY   (China)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Actin; Axon; Cdc42; Dedicator of cytokinesis; Dendrite; ELMO; Guanine nucleotide exchange factor; Neurite; Rac; Rho GTPase; Synapse

Indexed keywords

EID: 84894036915     PISSN: 19420889     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.26839     Document Type: Short Survey

References (84)

1. Côté JF, Vuori K. Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity. J Cell Sci 2002; 115:4901-13; PMID:12432077; http://dx.doi.org/10.1242/jcs.00219.
2. Meller N, Merlot S, Guda C. CZH proteins: a new family of Rho-GEFs. J Cell Sci 2005; 118:4937-46; PMID:16254241; http://dx.doi.org/10.1242/jcs.02671.
3. Rossman KL, Der CJ, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005; 6:167-80; PMID:15688002; http://dx.doi. org/10.1038/nrm1587.
4. Harada Y, Tanaka Y, Terasawa M, Pieczyk M, Habiro K, Katakai T, Hanawa-Suetsugu K, Kukimoto-Niino M, Nishizaki T, Shirouzu M, et al. DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood 2012; 119:4451-61; PMID:22461490; http://dx.doi.org/10.1182/blood-2012-01-407098.
5. Miyamoto Y, Yamauchi J. Cellular signaling of Dock family proteins in neural function. Cell Signal 2010; 22:175-82; PMID:19796679; http://dx.doi. org/10.1016/j.cellsig.2009.09.036.
6. Pankratz N, Dumitriu A, Hetrick KN, Sun M, Latourelle JC, Wilk JB, Halter C, Doheny KF, Gusella JF, Nichols WC, et al.; PSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic Laboratories. Copy number variation in familial Parkinson disease. PLoS One 2011; 6:e20988; PMID:21829596; http://dx.doi. org/10.1371/journal.pone.0020988.
7. Côté JF, Vuori K. GEF what? Dock180 and related proteins help Rac to polarize cells in new ways. Trends Cell Biol 2007; 17:383-93; PMID:17765544; http://dx.doi.org/10.1016/j.tcb.2007.05.001.
8. Brugnera E, Haney L, Grimsley C, Lu M, Walk SF, Tosello-Trampont AC, Macara IG, Madhani H, Fink GR, Ravichandran KS. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat Cell Biol 2002; 4:574-82; PMID:12134158.
9. Grimsley CM, Kinchen JM, Tosello-Trampont AC, Brugnera E, Haney LB, Lu M, Chen Q, Klingele D, Hengartner MO, Ravichandran KS. Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration. J Biol Chem 2004; 279:6087-97; PMID:14638695; http://dx.doi.org/10.1074/jbc. M307087200.
10. Li X, Gao X, Liu G, Xiong W, Wu J, Rao Y. Netrin signal transduction and the guanine nucleotide exchange factor DOCK180 in attractive signaling. Nat Neurosci 2008; 11:28-35; PMID:18066058; http://dx.doi.org/10.1038/nn2022.
11. Xu NJ, Henkemeyer M. Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning. Nat Neurosci 2009; 12:268-76; PMID:19182796; http://dx.doi.org/10.1038/nn.2254.
12. Franke K, Otto W, Johannes S, Baumgart J, Nitsch R, Schumacher S. miR-124-regulated RhoG reduces neuronal process complexity via ELMO/Dock180/Rac1 and Cdc42 signalling. EMBO J 2012; 31:2908-21; PMID:22588079; http://dx.doi. org/10.1038/emboj.2012.130.
13. Tu Y, Kucik DF, Wu C. Identification and kinetic analysis of the interaction between Nck-2 and DOCK180. FEBS Lett 2001; 491:193-9; PMID:11240126; http://dx.doi.org/10.1016/S0014-5793(01)02195-0.
14. Kim JY, Oh MH, Bernard LP, Macara IG, Zhang H. The RhoG/ELMO1/Dock180 signaling module is required for spine morphogenesis in hippocampal neurons. J Biol Chem 2011; 286:37615-24; PMID:21900250; http://dx.doi.org/10.1074/jbc. M111.268029.
15. Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z, Klibanov AL, Mandell JW, Ravichandran KS. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 2007; 450:430-4; PMID:17960134; http://dx.doi.org/10.1038/nature06329.
16. Lanoue V, Usardi A, Sigoillot SM, Talleur M, Iyer K, Mariani J, Isope P, Vodjdani G, Heintz N, Selimi F. The adhesion-GPCR BAI3, a gene linked to psychiatric disorders, regulates dendrite morphogenesis in neurons. Mol Psychiatry 2013; 18:943-50; PMID:23628982; http://dx.doi. org/10.1038/mp.2013.46.
17. Duman JG, Tzeng CP, Tu YK, Munjal T, Schwechter B, Ho TS, Tolias KF. The adhesion-GPCR BAI1 regulates synaptogenesis by controlling the recruitment of the Par3/Tiam1 polarity complex to synaptic sites. J Neurosci 2013; 33:6964-78; PMID:23595754; http://dx.doi.org/10.1523/JNEUROSCI.3978-12.2013.
18. Nishikimi A, Kukimoto-Niino M, Yokoyama S, Fukui Y. Immune regulatory functions of DOCK family proteins in health and disease. Exp Cell Res 2013; 319:2343-9; PMID:23911989; http://dx.doi. org/10.1016/j.yexcr.2013.07.024.
19. Cimino PJ, Sokal I, Leverenz J, Fukui Y, Montine TJ. DOCK2 is a microglial specific regulator of central nervous system innate immunity found in normal and Alzheimer's disease brain. Am J Pathol 2009; 175:1622-30; PMID:19729484; http://dx.doi.org/10.2353/ajpath.2009.090443.
20. Cimino PJ, Yang Y, Li X, Hemingway JF, Cherne MK, Khademi SB, Fukui Y, Montine KS, Montine TJ, Keene CD. Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease. Exp Mol Pathol 2013; 94:366-71; PMID:23318649; http://dx.doi. org/10.1016/j.yexmp.2013.01.002.
21. Kashiwa A, Yoshida H, Lee S, Paladino T, Liu Y, Chen Q, Dargusch R, Schubert D, Kimura H. Isolation and characterization of novel presenilin binding protein. J Neurochem 2000; 75:109-16; PMID:10854253; http://dx.doi. org/10.1046/j.1471-4159.2000.0750109.x.
22. Chen Q, Yoshida H, Schubert D, Maher P, Mallory M, Masliah E. Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation. Am J Pathol 2001; 159:1597-602; PMID:11696419; http://dx.doi.org/10.1016/S0002-9440(10)63005-2.
23. Tachi N, Hashimoto Y, Matsuoka M. MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's diseaserelated mutants of amyloid β precursor protein and presenilins. Biochem J 2012; 442:413-22; PMID:22115042; http://dx.doi.org/10.1042/BJ20100993.
24. Chen Q, Kimura H, Schubert D. A novel mechanism for the regulation of amyloid precursor protein metabolism. J Cell Biol 2002; 158:79-89; PMID:12093789; http://dx.doi.org/10.1083/jcb.200110151.
25. Bai N, Hayashi H, Aida T, Namekata K, Harada T, Mishina M, Tanaka K. Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity. Mol Brain 2013; 6:22; PMID:23641686; http://dx.doi. org/10.1186/1756-6606-6-22.
26. Namekata K, Kimura A, Kawamura K, Guo X, Harada C, Tanaka K, Harada T. Dock3 attenuates neural cell death due to NMDA neurotoxicity and oxidative stress in a mouse model of normal tension glaucoma. Cell Death Differ 2013; 20:1250-6; PMID:23852370; http://dx.doi.org/10.1038/cdd.2013.91.
27. Chen Q, Peto CA, Shelton GD, Mizisin A, Sawchenko PE, Schubert D. Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration. J Neurosci 2009; 29:118-30; PMID:19129390; http://dx.doi.org/10.1523/JNEUROSCI.3985-08.2009.
28. de Silva MG, Elliott K, Dahl HH, Fitzpatrick E, Wilcox S, Delatycki M, Williamson R, Efron D, Lynch M, Forrest S. Disruption of a novel member of a sodium/hydrogen exchanger family and DOCK3 is associated with an attention deficit hyperactivity disorder-like phenotype. J Med Genet 2003; 40:733-40; PMID:14569117; http://dx.doi. org/10.1136/jmg.40.10.733.
29. Namekata K, Watanabe H, Guo X, Kittaka D, Kawamura K, Kimura A, Harada C, Harada T. Dock3 regulates BDNF-TrkB signaling for neurite outgrowth by forming a ternary complex with Elmo and RhoG. Genes Cells 2012; 17:688-97; PMID:22734669; http://dx.doi.org/10.1111/j.1365-2443.2012.01616.x.
30. Namekata K, Harada C, Taya C, Guo X, Kimura H, Parada LF, Harada T. Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex. Proc Natl Acad Sci U S A 2010; 107:7586-91; PMID:20368433; http://dx.doi. org/10.1073/pnas.0914514107.
31. Namekata K, Harada C, Guo X, Kimura A, Kittaka D, Watanabe H, Harada T. Dock3 stimulates axonal outgrowth via GSK-3β-mediated microtubule assembly. J Neurosci 2012; 32:264-74; PMID:22219288; http://dx.doi.org/10.1523/JNEUROSCI.4884-11.2012.
32. Chen Q, Chen TJ, Letourneau PC, Costa LdaF, Schubert D. Modifier of cell adhesion regulates N-cadherin-mediated cell-cell adhesion and neurite outgrowth. J Neurosci 2005; 25:281-90; PMID:15647471; http://dx.doi.org/10.1523/JNEUROSCI.3692-04.2005.
33. Caspi E, Rosin-Arbesfeld R. A novel functional screen in human cells identifies MOCA as a negative regulator of Wnt signaling. Mol Biol Cell 2008; 19:4660-74; PMID:18716063; http://dx.doi.org/10.1091/mbc. E07-10-1046.
34. Pagnamenta AT, Bacchelli E, de Jonge MV, Mirza G, Scerri TS, Minopoli F, Chiocchetti A, Ludwig KU, Hoffmann P, Paracchini S, et al.; International Molecular Genetic Study Of Autism Consortium. Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia. Biol Psychiatry 2010; 68:320-8; PMID:20346443; http://dx.doi.org/10.1016/j. biopsych.2010.02.002.
35. Maestrini E, Pagnamenta AT, Lamb JA, Bacchelli E, Sykes NH, Sousa I, Toma C, Barnby G, Butler H, Winchester L, et al.; IMGSAC. High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2LDOCK4 gene region in autism susceptibility. Mol Psychiatry 2010; 15:954-68; PMID:19401682; http://dx.doi.org/10.1038/mp.2009.34.
36. Poelmans G, Buitelaar JK, Pauls DL, Franke B. A theoretical molecular network for dyslexia: integrating available genetic findings. Mol Psychiatry 2011; 16:365-82; PMID:20956978; http://dx.doi. org/10.1038/mp.2010.105.
37. Alkelai A, Lupoli S, Greenbaum L, Kohn Y, Kanyas-Sarner K, Ben-Asher E, Lancet D, Macciardi F, Lerer B. DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population. Int J Neuropsychopharmacol 2012; 15:459-69; PMID:21682944; http://dx.doi.org/10.1017/S1461145711000903.
38. Xiao Y, Peng Y, Wan J, Tang G, Chen Y, Tang J, Ye WC, Ip NY, Shi L. The atypical guanine nucleotide exchange factor Dock4 regulates neurite differentiation through modulation of Rac1 GTPase and actin dynamics. J Biol Chem 2013; 288:20034-45; PMID:23720743; http://dx.doi.org/10.1074/jbc. M113.458612.
39. Ueda S, Fujimoto S, Hiramoto K, Negishi M, Katoh H. Dock4 regulates dendritic development in hippocampal neurons. J Neurosci Res 2008; 86:3052-61; PMID:18615735; http://dx.doi.org/10.1002/jnr.21763.
40. Ueda S, Negishi M, Katoh H. Rac GEF Dock4 interacts with cortactin to regulate dendritic spine formation. Mol Biol Cell 2013; 24:1602-13; PMID:23536706; http://dx.doi.org/10.1091/mbc.E12-11-0782.
41. Franco SJ, Martinez-Garay I, Gil-Sanz C, Harkins-Perry SR, Müller U. Reelin regulates cadherin function via Dab1/Rap1 to control neuronal migration and lamination in the neocortex. Neuron 2011; 69:482-97; PMID:21315259; http://dx.doi.org/10.1016/j. neuron.2011.01.003.
42. Xie Z, Huganir RL, Penzes P. Activity-dependent dendritic spine structural plasticity is regulated by small GTPase Rap1 and its target AF-6. Neuron 2005; 48:605-18; PMID:16301177; http://dx.doi. org/10.1016/j.neuron.2005.09.027.
43. Miyamoto Y, Yamauchi J, Sanbe A, Tanoue A. Dock6, a Dock-C subfamily guanine nucleotide exchanger, has the dual specificity for Rac1 and Cdc42 and regulates neurite outgrowth. Exp Cell Res 2007; 313:791-804; PMID:17196961; http://dx.doi. org/10.1016/j.yexcr.2006.11.017.
44. Miyamoto Y, Torii T, Yamamori N, Ogata T, Tanoue A, Yamauchi J. Akt and PP2A reciprocally regulate the guanine nucleotide exchange factor Dock6 to control axon growth of sensory neurons. Sci Signal 2013; 6:ra15; PMID:23462102; http://dx.doi. org/10.1126/scisignal.2003661.
45. Watabe-Uchida M, John KA, Janas JA, Newey SE, Van Aelst L. The Rac activator DOCK7 regulates neuronal polarity through local phosphorylation of stathmin/Op18. Neuron 2006; 51:727-39; PMID:16982419; http://dx.doi.org/10.1016/j. neuron.2006.07.020.
46. Yang YT, Wang CL, Van Aelst L. DOCK7 interacts with TACC3 to regulate interkinetic nuclear migration and cortical neurogenesis. Nat Neurosci 2012; 15:1201-10; PMID:22842144; http://dx.doi. org/10.1038/nn.3171.
47. Majewski Ł, Sobczak M, Havrylov S, Jóźwiak J, Re{ogonek}dowicz MJ. Dock7: a GEF for Rho-family GTPases and a novel myosin VI-binding partner in neuronal PC12 cells. Biochem Cell Biol 2012; 90:565-74; PMID:22475431; http://dx.doi.org/10.1139/o2012-009.
48. Yamauchi J, Miyamoto Y, Chan JR, Tanoue A. ErbB2 directly activates the exchange factor Dock7 to promote Schwann cell migration. J Cell Biol 2008; 181:351-65; PMID:18426980; http://dx.doi. org/10.1083/jcb.200709033.
49. Yamauchi J, Miyamoto Y, Hamasaki H, Sanbe A, Kusakawa S, Nakamura A, Tsumura H, Maeda M, Nemoto N, Kawahara K, et al. The atypical Guanine-nucleotide exchange factor, dock7, negatively regulates schwann cell differentiation and myelination. J Neurosci 2011; 31:12579-92; PMID:21880919; http://dx.doi.org/10.1523/JNEUROSCI.2738-11.2011.
50. Nellist M, Burgers PC, van den Ouweland AM, Halley DJ, Luider TM. Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. Biochem Biophys Res Commun 2005; 333:818-26; PMID:15963462; http://dx.doi.org/10.1016/j. bbrc.2005.05.175.
51. Guo L, Ying W, Zhang J, Yuan Y, Qian X, Wang J, Yang X, He F. Tandem affinity purification and identification of the human TSC1 protein complex. Acta Biochim Biophys Sin (Shanghai) 2010; 42:266-73; PMID:20383465; http://dx.doi.org/10.1093/abbs/gmq014.
52. Blasius AL, Brandl K, Crozat K, Xia Y, Khovananth K, Krebs P, Smart NG, Zampolli A, Ruggeri ZM, Beutler BA. Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological function. Proc Natl Acad Sci U S A 2009; 106:2706-11; PMID:19202056; http://dx.doi.org/10.1073/pnas.0813208106.
53. Ruusala A, Aspenström P. Isolation and characterisation of DOCK8, a member of the DOCK180-related regulators of cell morphology. FEBS Lett 2004; 572:159-66; PMID:15304341; http://dx.doi.org/10.1016/j.febslet.2004.06.095.
54. Ham H, Guerrier S, Kim J, Schoon RA, Anderson EL, Hamann MJ, Lou Z, Billadeau DD. Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity. J Immunol 2013; 190:3661-9; PMID:23455509; http://dx.doi.org/10.4049/jimmunol.1202792.
55. Vinci G, Chantot-Bastaraud S, El Houate B, Lortat-Jacob S, Brauner R, McElreavey K. Association of deletion 9p, 46,XY gonadal dysgenesis and autistic spectrum disorder. Mol Hum Reprod 2007; 13:685-9; PMID:17644778; http://dx.doi.org/10.1093/molehr/gam045.
56. Griggs BL, Ladd S, Saul RA, DuPont BR, Srivastava AK. Dedicator of cytokinesis 8 is disrupted in two patients with mental retardation and developmental disabilities. Genomics 2008; 91:195-202; PMID:18060736; http://dx.doi.org/10.1016/j. ygeno.2007.10.011.
57. Nishikimi A, Meller N, Uekawa N, Isobe K, Schwartz MA, Maruyama M. Zizimin2: a novel, DOCK180-related Cdc42 guanine nucleotide exchange factor expressed predominantly in lymphocytes. FEBS Lett 2005; 579:1039-46; PMID:15710388; http://dx.doi.org/10.1016/j.febslet.2005.01.006.
58. Kuramoto K, Negishi M, Katoh H. Regulation of dendrite growth by the Cdc42 activator Zizimin1/Dock9 in hippocampal neurons. J Neurosci Res 2009; 87:1794-805; PMID:19156867; http://dx.doi.org/10.1002/jnr.21997.
59. Detera-Wadleigh SD, Liu CY, Maheshwari M, Cardona I, Corona W, Akula N, Steele CJ, Badner JA, Kundu M, Kassem L, et al.; NIMH Genetics Initiative for Bipolar Disorder Consortium. Sequence variation in DOCK9 and heterogeneity in bipolar disorder. Psychiatr Genet 2007; 17:274-86; PMID:17728666; http://dx.doi.org/10.1097/YPG.0b013e328133f352.
60. Nava C, Keren B, Mignot C, Rastetter A, Chantot-Bastaraud S, Faudet A, Fonteneau E, Amiet C, Laurent C, Jacquette A, et al. Prospective diagnostic analysis of copy number variants using SNP microarrays in individuals with autism spectrum disorders. Eur J Hum Genet 2013; PMID:23632794; http://dx.doi.org/10.1038/ejhg.2013.88.
61. Pertz OC, Wang Y, Yang F, Wang W, Gay LJ, Gristenko MA, Clauss TR, Anderson DJ, Liu T, Auberry KJ, et al. Spatial mapping of the neurite and soma proteomes reveals a functional Cdc42/Rac regulatory network. Proc Natl Acad Sci U S A 2008; 105:1931-6; PMID:18245386; http://dx.doi. org/10.1073/pnas.0706545105.
62. Upadhyay G, Goessling W, North TE, Xavier R, Zon LI, Yajnik V. Molecular association between beta-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/beta-catenin signaling. Oncogene 2008; 27:5845-55; PMID:18641688; http://dx.doi.org/10.1038/onc.2008.202.
63. Attar MA, Santy LC. The scaffolding protein GRASP/Tamalin directly binds to Dock180 as well as to cytohesins facilitating GTPase crosstalk in epithelial cell migration. BMC Cell Biol 2013; 14:9; PMID:23441967; http://dx.doi. org/10.1186/1471-2121-14-9.
64. Tachibana M, Kiyokawa E, Hara S, Iemura S, Natsume T, Manabe T, Matsuda M. Ankyrin repeat domain 28 (ANKRD28), a novel binding partner of DOCK180, promotes cell migration by regulating focal adhesion formation. Exp Cell Res 2009; 315:863-76; PMID:19118547; http://dx.doi.org/10.1016/j. yexcr.2008.12.005.
65. Hara S, Kiyokawa E, Iemura S, Natsume T, Wassmer T, Cullen PJ, Hiai H, Matsuda M. The DHR1 domain of DOCK180 binds to SNX5 and regulates cation-independent mannose 6-phosphate receptor transport. Mol Biol Cell 2008; 19:3823-35; PMID:18596235; http://dx.doi.org/10.1091/mbc. E08-03-0314.
66. Sanui T, Inayoshi A, Noda M, Iwata E, Stein JV, Sasazuki T, Fukui Y. DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1. Blood 2003; 102:2948-50; PMID:12829596; http://dx.doi.org/10.1182/blood-2003-01-0173.
67. Lu M, Kinchen JM, Rossman KL, Grimsley C, Hall M, Sondek J, Hengartner MO, Yajnik V, Ravichandran KS. A Steric-inhibition model for regulation of nucleotide exchange via the Dock180 family of GEFs. Curr Biol 2005; 15:371-7; PMID:15723800; http://dx.doi.org/10.1016/j. cub.2005.01.050.
68. Katoh H, Negishi M. RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo. Nature 2003; 424:461-4; PMID:12879077; http://dx.doi.org/10.1038/nature01817.
69. Kiyokawa E, Hashimoto Y, Kobayashi S, Sugimura H, Kurata T, Matsuda M. Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev 1998; 12:3331-6; PMID:9808620; http://dx.doi. org/10.1101/gad.12.21.3331.
70. Nishihara H, Maeda M, Oda A, Tsuda M, Sawa H, Nagashima K, Tanaka S. DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines. Blood 2002; 100:3968-74; PMID:12393632; http://dx.doi.org/10.1182/blood-2001-11-0032.
71. Sanders MA, Ampasala D, Basson MD. DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV. J Biol Chem 2009; 284:27-35; PMID:19004829; http://dx.doi.org/10.1074/jbc.M808010200.
72. Govek EE, Newey SE, Van Aelst L. The role of the Rho GTPases in neuronal development. Genes Dev 2005; 19:1-49; PMID:15630019; http://dx.doi. org/10.1101/gad.1256405.
73. Hiramoto-Yamaki N, Takeuchi S, Ueda S, Harada K, Fujimoto S, Negishi M, Katoh H. Ephexin4 and EphA2 mediate cell migration through a RhoGdependent mechanism. J Cell Biol 2010; 190:461-77; PMID:20679435; http://dx.doi.org/10.1083/jcb.201005141.
74. Meller N, Irani-Tehrani M, Ratnikov BI, Paschal BM, Schwartz MA. The novel Cdc42 guanine nucleotide exchange factor, zizimin1, dimerizes via the Cdc42-binding CZH2 domain. J Biol Chem 2004; 279:37470-6; PMID:15247287; http://dx.doi.org/10.1074/jbc.M404535200.
75. Terasawa M, Uruno T, Mori S, Kukimoto-Niino M, Nishikimi A, Sanematsu F, Tanaka Y, Yokoyama S, Fukui Y. Dimerization of DOCK2 is essential for DOCK2-mediated Rac activation and lymphocyte migration. PLoS One 2012; 7:e46277; PMID:23050005; http://dx.doi.org/10.1371/journal.pone.0046277.
76. Patel M, Pelletier A, Côté JF. Opening up on ELMO regulation: New insights into the control of Rac signaling by the DOCK180/ELMO complex. Small GTPases 2011; 2:268-75; PMID:22292130; http://dx.doi.org/10.4161/sgtp.2.5.17716.
77. Premkumar L, Bobkov AA, Patel M, Jaroszewski L, Bankston LA, Stec B, Vuori K, Côté JF, Liddington RC. Structural basis of membrane targeting by the Dock180 family of Rho family guanine exchange factors (Rho-GEFs). J Biol Chem 2010; 285:13211-22; PMID:20167601; http://dx.doi.org/10.1074/jbc.M110.102517.
78. Kobayashi S, Shirai T, Kiyokawa E, Mochizuki N, Matsuda M, Fukui Y. Membrane recruitment of DOCK180 by binding to PtdIns(3,4,5)P3. Biochem J 2001; 354:73-8; PMID:11171081; http://dx.doi. org/10.1042/0264-6021:3540073.
79. Côté JF, Motoyama AB, Bush JA, Vuori K. A novel and evolutionarily conserved PtdIns(3,4,5) P3-binding domain is necessary for DOCK180 signalling. Nat Cell Biol 2005; 7:797-807; PMID:16025104; http://dx.doi.org/10.1038/ncb1280.
80. Kunisaki Y, Nishikimi A, Tanaka Y, Takii R, Noda M, Inayoshi A, Watanabe K, Sanematsu F, Sasazuki T, Sasaki T, et al. DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis. J Cell Biol 2006; 174:647-52; PMID:16943182; http://dx.doi.org/10.1083/jcb.200602142.
81. Kanai A, Ihara S, Ohdaira T, Shinohara-Kanda A, Iwamatsu A, Fukui Y. Identification of DOCK4 and its splicing variant as PIP3 binding proteins. IUBMB Life 2008; 60:467-72; PMID:18459162; http://dx.doi.org/10.1002/iub.67.
82. Meller N, Westbrook MJ, Shannon JD, Guda C, Schwartz MA. Function of the N-terminus of zizimin1: autoinhibition and membrane targeting. Biochem J 2008; 409:525-33; PMID:17935486; http://dx.doi.org/10.1042/BJ20071263.
83. Feng H, Hu B, Liu KW, Li Y, Lu X, Cheng T, Yiin JJ, Lu S, Keezer S, Fenton T, et al. Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans. J Clin Invest 2011; 121:4670-84; PMID:22080864; http://dx.doi.org/10.1172/JCI58559.
84. Feng H, Hu B, Jarzynka MJ, Li Y, Keezer S, Johns TG, Tang CK, Hamilton RL, Vuori K, Nishikawa R, et al. Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis. Proc Natl Acad Sci U S A 2012; 109:3018-23; PMID:22323579; http://dx.doi. org/10.1073/pnas.1121457109.